Home | Welcome to Contract Pharma   
Last Updated Sunday, May 19 2013
Print RSS Feed

Breaking News

Related Searches: Financial Reports •
Financial Report: Patheon 1Q

March 15, 2010
Revenues from commercial operations increased 9% to $128.1 million in the quarter, aided by currency fluctuations.  Read More »
Complete Response Letter Issued for Exenatide LAR NDA

March 15, 2010
Amylin Pharmaceuticals, Lilly and Alkermes received a complete response letter from the FDA for their NDA for Bydureon (exenatide extended-release injectable suspension).  Read More »
Merck, Portola’s Phase II Study Shows Betrixaban Reduced Bleeding

March 15, 2010
Portola Pharmaceuticals and Merck achieved positive results from EXPLORE-Xa, a Phase II dose finding study of investigational oral direct Factor Xa inhibitor betrixaban.  Read More »
Two Pfizer Cancer Drugs Fail Trials

March 12, 2010
Pfizer has discontinued the Phase III trial A4021018 (ADVIGO 1018), which examined the investigational compound figitumumab (CP-751,871) in combination with erlotinib as a second/third-line treatment in patients with previously treated advanced non-adenoc  Read More »
Quintiles Opens Kenya Office

March 12, 2010
Quintiles has opened an office in Nairobi, Kenya, expanding its capacity to provide clinical research services in Africa.   Read More »
Baxter Flu Vax Shows Promise in Phase III

March 12, 2010
Baxter and DynPort Vaccine Co. (DVC), achieved positive results from a Phase III study measuring the clinical efficacy for Preflucel, a trivalent seasonal flu vaccine.  Read More »
Bayer’s Cipro CF Drug Gets Orphan Designation

March 11, 2010
Bayer HealthCare Pharmaceuticals was granted an orphan drug designation by the FDA for ciprofloxacin dry powder inhaler (DPI) for management of pulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis (CF) patients.  Read More »
Bio-Processing Alliance Launches Consulting Business

March 11, 2010
Bio-Processing Alliance, Inc. (BPAI) has launched a biologics drug development consulting business to provide support the management of complex biologics programs from concept, through to development and Phase I-III trials.  Read More »
Lurasidone NDA Accepted for Review

March 11, 2010
The FDA has accepted for review Dainippon Sumitomo Pharma America’s lurasidone NDA for the treatment of acute schizophrenia.   Read More »
Cerulean Pharma

March 10, 2010
New CMO, finance roles at Cambridge-based biotech  Read More »
Kendle Launches Biostatistics Infrastructure

March 10, 2010
New data platform to speed sharing, security  Read More »
Abbott Acquires Facet

March 10, 2010
Abbott buys biotech at $27 per share, trumping Biogen Idec's $17.50 bid  Read More »
Exelixis Restructures, Cuts 40% of Workforce

March 9, 2010
Exelixis, Inc. is restructuring as part of its continued strategy to focus resources on the development of its key late-stage compounds, XL184, XL147 and XL765.  Read More »
Lonza, Odyssey Thera Enter Protein Assay Pact

March 9, 2010
Lonza and Odyssey Thera, Inc. have signed an agreement under which Lonza will make Odyssey's Protein-fragment Complementation Assay (PCA) technology, as part of compound profiling services available to life science researchers.  Read More »
Almac Wins Aer Lingus Excellence Award

March 9, 2010
Almac has received the Aer Lingus Viscount Award for Overall Excellence. The annual award is given for contributing to the Northern Irish economy and improving business relationships between the UK and Ireland.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: